ETTX - Entasis Therapeutics Holdings - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

ETTX is currently covered by 1 analysts with an average price target of $1.75. This is a potential upside of $1.75 (0%) from yesterday's end of day stock price of $0.

Entasis Therapeutics Holdings's activity chart (see below) currently has 8 price targets and 7 ratings on display. The stock rating distribution of ETTX is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 47.22% with an average time for these price targets to be met of 17.17 days.

Highest price target for ETTX is $2, Lowest price target is $2, average price target is $1.75.

Most recent stock forecast was given by LOUISE CHEN from CANTOR FITZGERALD on 06-May-2022. First documented stock forecast 22-Oct-2018.

Best performing analysts who are covering ETTX - Entasis Therapeutics Holdings:

Martin Auster Robert Driscoll Louise Chen Matthew Luchini Ed Arce Jim Molloy

Currently out of the existing stock ratings of ETTX, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$-0.19 (-8.68%)

1 years 11 months 19 days ago

1/1 (100%)

$0.15 (8.11%)

17

Hold

2

$-0.19 (-8.68%)

2 years 1 months 9 days ago

1/1 (100%)

$0.11 (5.82%)

68

Hold

1.8

$-0.39 (-17.81%)

9

2 years 1 months 17 days ago

1/3 (33.33%)

$0.15 (9.09%)

7

Hold

1.8

$-0.39 (-17.81%)

6

2 years 1 months 21 days ago

1/2 (50%)

$0.05 (2.86%)

11

Buy

7

$4.81 (219.63%)

18

2 years 6 months 4 days ago

0/2 (0%)

$7.44 (147.95%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ETTX (Entasis Therapeutics Holdings) average time for price targets to be met?

On average it took 17.17 days on average for the stock forecasts to be realized with a an average price target met ratio 47.22

Which analyst has the current highest performing score on ETTX (Entasis Therapeutics Holdings) with a proven track record?

MARTIN AUSTER

Which analyst has the current lower performing score on ETTX (Entasis Therapeutics Holdings) with a proven track record?

JIM MOLLOY

Which analyst has the most public recommendations on ETTX (Entasis Therapeutics Holdings)?

Martin Auster has 8 price targets and 3 ratings on ETTX

Which analyst is the currently most bullish on ETTX (Entasis Therapeutics Holdings)?

Matthew Luchini with highest potential upside - $4.81

Which analyst is the currently most reserved on ETTX (Entasis Therapeutics Holdings)?

Robert Driscoll with lowest potential downside - -$0.39

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?